Strategies to Curb High Drug Prices
August 26, 2016 | Hagop M. Kantarjian

Table of Contents
Author(s)
Hagop M. Kantarjian
Nonresident Fellow in Health PolicyNonresident fellow Hagop Kantarjian, chair of the Department of Leukemia at the MD Anderson Cancer, co-authors an article on countering pharmaceutical industry efforts to delay the release of affordable generic drugs in the United States.
Read his paper in Blood, a weekly medical journal published by the American Society of Hematology.